We are live on ! Find out more
IRC

Investors Research Corp Portfolio holdings

AUM $559M
1-Year Est. Return 21.55%
This Fund
S&P 500
This Quarter Est. Return
-13.12%
1 Year Est. Return
+21.55%
3 Year Est. Return
+57.22%
5 Year Est. Return
+62.75%
10 Year Est. Return
AUM
$333M
AUM Growth
-$21.4M
Cap. Flow
+$30.5M
Cap. Flow %
9.18%
Top 10 Hldgs %
15.76%
Holding
1,207
New
106
Increased
189
Reduced
131
Closed
54

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$566K
2
AMCR icon
Amcor
AMCR
+$272K
3
T icon
AT&T
T
+$251K
4
MOS icon
The Mosaic Company
MOS
+$214K
5
DVN icon
Devon Energy
DVN
+$210K

Sector Composition

Rank Sector Weight
1 Financials 10%
2 Consumer Discretionary 8.29%
3 Technology 6.56%
4 Industrials 5.85%
5 Materials 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGNW
1176
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
-7
Closed
PDCE
1177
DELISTED
PDC Energy, Inc.
PDCE
-2,210
Closed -$161K
CPUH.WS
1178
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$0 ﹤0.01%
12
CPUH
1179
DELISTED
Compute Health Acquisition Corp.
CPUH
$0 ﹤0.01%
48
TDW.WS.B
1180
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$0 ﹤0.01%
1,010
TCRR
1181
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$0 ﹤0.01%
15
CDAK
1182
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$0 ﹤0.01%
22
VLTA
1183
DELISTED
Volta Inc.
VLTA
-1
Closed
SFT
1184
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-1
Closed
SRNE
1185
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$0 ﹤0.01%
50
SVFA
1186
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$0 ﹤0.01%
50
SVFAW
1187
DELISTED
SVF Investment Corp. Warrant
SVFAW
$0 ﹤0.01%
10
EPHYW
1188
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$0 ﹤0.01%
22
COLIW
1189
DELISTED
Colicity Inc. Warrant
COLIW
$0 ﹤0.01%
+10
New +$3
COLI
1190
DELISTED
Colicity Inc. Class A Common Stock
COLI
$0 ﹤0.01%
+50
New +$490
NDACW
1191
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$0 ﹤0.01%
+10
New +$4
NDAC
1192
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
$0 ﹤0.01%
+50
New +$489
LMACW
1193
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$0 ﹤0.01%
7
LMACA
1194
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
$0 ﹤0.01%
35
LOGC
1195
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$0 ﹤0.01%
89
TPGY
1196
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
-1
Closed
CRU.WS
1197
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$0 ﹤0.01%
21
KCAC.U
1198
DELISTED
Kensington Capital Acquisition Corp. IV Units, each consisting of one Class A Ordinary Share, one Class 1 redeemable Warrant and one Class 2 redeemable Warrant
KCAC.U
$0 ﹤0.01%
+45
New +$454
EMWP
1199
DELISTED
Eros Media World PLC
EMWP
$0 ﹤0.01%
75
ZNGA
1200
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-10
Closed

Similar funds

Investors Research Corp's Q2 2022 Portfolio in Review

As of Q2 2022, Investors Research Corp held 1,207 positions worth $333M, down 6% from $354M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Investors Research Corp deployed $30.5M of net new capital in Q2 2022, opening 106 new positions and adding to 189 existing holdings. Its largest new stake was Best Buy: 12,620 shares worth $823K.

By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 9.4% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $566K trimmed.

  • Investors Research Corp's largest Q2 2022 buy was Best Buy: 12,620 shares worth $823K.
  • Investors Research Corp added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q2 2022, an estimated $1.09M increase.
  • Investors Research Corp's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $566K.
  • Investors Research Corp fully exited Amcor in Q2 2022, selling an estimated $272K.
  • Investors Research Corp's ten largest holdings make up 16% of its $333M portfolio in Q2 2022.
  • Investors Research Corp opened 106 new positions and closed 54 in Q2 2022.
  • Investors Research Corp's portfolio value fell 6% quarter-over-quarter to $333M.

Based on Investors Research Corp's 13F filing for Q2 2022, filed 21 Jul 2022.